Cargando…

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors

Zika virus (ZIKV) emerged on a global scale and no licensed vaccine ensures long-lasting anti-ZIKV immunity. Here we report the design and comparative evaluation of four replication-deficient chimpanzee adenoviral (ChAdOx1) ZIKV vaccine candidates comprising the addition or deletion of precursor mem...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-Camacho, César, Abbink, Peter, Larocca, Rafael A., Dejnirattisai, Wanwisa, Boyd, Michael, Badamchi-Zadeh, Alex, Wallace, Zoë R., Doig, Jennifer, Velazquez, Ricardo Sanchez, Neto, Roberto Dias Lins, Coelho, Danilo F., Kim, Young Chan, Donald, Claire L., Owsianka, Ania, De Lorenzo, Giuditta, Kohl, Alain, Gilbert, Sarah C., Dorrell, Lucy, Mongkolsapaya, Juthathip, Patel, Arvind H., Screaton, Gavin R., Barouch, Dan H., Hill, Adrian V. S., Reyes-Sandoval, Arturo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015009/ https://www.ncbi.nlm.nih.gov/pubmed/29934593 http://dx.doi.org/10.1038/s41467-018-04859-5

Ejemplares similares

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
por: López-Camacho, César, et al.
Publicado: (2020)

Lectin Switching During Dengue Virus Infection
por: Dejnirattisai, Wanwisa, et al.
Publicado: (2011)

Sensing of Immature Particles Produced by Dengue Virus Infected Cells Induces an Antiviral Response by Plasmacytoid Dendritic Cells
por: Décembre, Elodie, et al.
Publicado: (2014)

The immunology of Zika Virus
por: Culshaw, Abigail, et al.
Publicado: (2018)

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus
por: Dejnirattisai, Wanwisa, et al.
Publicado: (2016)

Immunogenicity and Cross-Reactivity of Rhesus Adenoviral Vectors
por: Iampietro, M. Justin, et al.
Publicado: (2018)

Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors
por: Abbink, Peter, et al.
Publicado: (2018)

Anti-Dengue E-dimer epitope human antibodies have therapeutic activity against Zika virus infection
por: Fernandez, Estefania, et al.
Publicado: (2017)

Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice
por: Salazar, Vanessa, et al.
Publicado: (2019)

Recent advances in understanding dengue
por: Yacoub, Sophie, et al.
Publicado: (2016)

CryoEM structures of the multimeric secreted NS1, a major factor for dengue hemorrhagic fever
por: Shu, Bo, et al.
Publicado: (2022)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer, Katie, et al.
Publicado: (2017)

Flavivirus maturation leads to the formation of an occupied lipid pocket in the surface glycoproteins
por: Renner, Max, et al.
Publicado: (2021)

Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
por: Rouvinski, Alexander, et al.
Publicado: (2017)

The epitope arrangement on flavivirus particles contributes to Mab C10’s extraordinary neutralization breadth across Zika and dengue viruses
por: Sharma, Arvind, et al.
Publicado: (2021)

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
por: Dejnirattisai, Wanwisa, et al.
Publicado: (2022)

Alpha-defensin 5 differentially modulates adenovirus vaccine vectors from different serotypes in vivo
por: Tartaglia, Lawrence J., et al.
Publicado: (2019)

Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge
por: Cox, Freek, et al.
Publicado: (2018)

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection
por: Hartnell, Felicity, et al.
Publicado: (2019)

Guillain-Barré Syndrome Following Zika Virus Infection Is Associated With a Diverse Spectrum of Peripheral Nerve Reactive Antibodies
por: Davies, Alexander J., et al.
Publicado: (2022)

Antibodies and tuberculosis
por: Jacobs, Ashley J., et al.
Publicado: (2016)

A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines
por: Peruzzi, Daniela, et al.
Publicado: (2009)

Therapeutic Efficacy of Vectored PGT121 Gene Delivery in HIV-1-Infected Humanized Mice
por: Badamchi-Zadeh, Alexander, et al.
Publicado: (2018)

Transient CD4(+) T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses
por: Provine, Nicholas M., et al.
Publicado: (2016)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
por: López-Camacho, César, et al.
Publicado: (2019)

Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection
por: Blass, Eryn, et al.
Publicado: (2018)

Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine
por: Watanabe, Yasunori, et al.
Publicado: (2021)

Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine
por: Watanabe, Yasunori, et al.
Publicado: (2021)

A Simplified Positive-Sense-RNA Virus Construction Approach That Enhances Analysis Throughput
por: Siridechadilok, Bunpote, et al.
Publicado: (2013)

Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques
por: Yang, Xi, et al.
Publicado: (2019)

Invariant NKT Cell Response to Dengue Virus Infection in Human
por: Matangkasombut, Ponpan, et al.
Publicado: (2014)

The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies
por: Spencer, Alexandra J, et al.
Publicado: (2022)

Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels
por: Harvala, Heli, et al.
Publicado: (2020)

Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection
por: Liu, Jiaojiao, et al.
Publicado: (2021)

Autoantibody-dependent amplification of inflammation in SLE
por: Lou, Hantao, et al.
Publicado: (2020)

Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy
por: Wessel, Alex W., et al.
Publicado: (2020)

Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge
por: De Lorenzo, Giuditta, et al.
Publicado: (2020)

Vaccine Protection Against Zika Virus from Brazil
por: Larocca, Rafael A., et al.
Publicado: (2016)

Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum
por: Huo, Jiandong, et al.
Publicado: (2022)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g8q9t6qf27i6o9b9rhei0rp4eu